38. Dantzer F, Ame´ JC, Schreiber V, Nakamura J, Me´nissier-de Murcia J, de Murcia G. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair. Methods Enzymol. 2006;409:493–510. 39. Miao ZH, Player A, Shankavaram U, Wang YH, Zimonjic DB, Lorenzi PL, Liao ZY, Liu H, Shimura T, Zhang HL. Non-classic functions of human topoisomerase I: genome-wide and pharmacologic analyses. Cancer Res. 2007;67:8752–61. 40. Zhu W, Depamphilis ML. Selective killing of cancer cells by suppression of geminin activity. Cancer Res. 2009;69:4870–7. 41. Livesey G, Wilkinson JA, Roe M, Faulks R, Clark S, Brown JC, Kennedy H, Elia M. Inﬂuence of the physical form of barley grain on the digestion of its starch in the human small intestine and implications for health. Am J Clin Nutr. 1995;61:75–81. 42. Topping D, Bird A, Toden S, Conlon M, Noakes M, King R, Mann G, Li Z, Morell M. Resistant starch as a contributor to the health beneﬁts of whole grains. In: Marquart L, Jacobs D, McIntosh G, Poutanen K, Reicks M, editors. Whole grains and health. Ames (IA): Blackwell Pub- lishers; 2007. p. 219–27. 43. Bird AR, Vuaran MS, King RA, Noakes M, Keogh J, Morell MK, Topping DL. Wholegrain foods made from a novel high-amylose barley variety (Himalaya 292) improve indices of bowel health in human sub- jects. Br J Nutr. 2008;99:1032–40. 44. Cats A, De Vries EG, Mulder NH, Kleibeuker JH. Regional differences of physiological functions and cancer susceptibility in the human large intestine. Int J Oncol. 1996;9:1055–69. 45. Muir JG, Yeow EG, Keogh J, Pizzey C, Bird AR, O’Dear K, Macrae FA. Combining wheat bran with resistant starch has more beneﬁcial effects on fecal indices than does wheat bran alone. Am J Clin Nutr. 2004;79:1020–8. 46. Topping DL, Mock S, Trimble RP, Storer GB, Illman RJ. Effects of varying the content and proportions of gum arabic and cellulose on caecal volatile fatty acid concentrations in the rat. Nutr Res. 1988;8: 1013–20. 47. Morita T, Tanabe H, Ito H, Sugiyama K, Kiriyama S. Long-term ingestion of insoluble dietary ﬁber increases luminal mucin content but has no effect on nutrient absorption in rats. Biosci Biotechnol Biochem. 2008;72:767–72. 48. Brown I, Warhurst M, Arcot J, Playne M, Illman RJ, Topping DL. Fecal starch and volatile fatty acid excretion and Biﬁdobacterium longum numbers are higher in pigs fed a high amylose starch than in those fed amylopectin. J Nutr. 1997;127:1822–7. 49. Abell GC, Cooke CM, Bennett CN, Conlon MA, McOrist AL. Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol Ecol. 2008;66:505–15. 50. Silvi S, Rumney CJ, Cresci A, Rowland IR. Resistant starch modiﬁes gut microﬂora and microbial metabolism in human ﬂora-associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol. 1999;86:521–30. 51. Bird AR, Vuaran M, Crittenden R, Hayakawa T, Playne MJ, Brown IL, Topping DL. Comparative effects of a high amylose starch and a fructooligosaccharide on fecal biﬁdobacteria numbers and short-chain fatty acids in pigs fed Biﬁdobacterium animalis. Dig Dis Sci. 2009; 54:947–54. 52. Mandir N, Englyst H, Goodlad RA. Resistant carbohydrates stimulate cell proliferation and crypt ﬁssion in wild-type mice and in the ApcMin/+ mouse model of intestinal cancer association with enhanced polyp development. Br J Nutr. 2008;100:711–21. 840 Conlon et al.